Following the introduction of routine Prostate Specific Antigen (PSA) screening in the early
1990′ s, Prostate Cancer (PCa) is often detected at an early stage. There are also a …

Prostate cancer is the most commonly diagnosed non-cutaneous neoplasm in men in the
United States and the second leading cause of cancer mortality. One in 7 men will be …

Simple Summary Stereotactic body radiotherapy, a type of high-precision radiotherapy
delivering high doses within few treatment sessions has proven to be effective and well …

Background Genomic classifiers (GC) have been shown to improve risk stratification post
prostatectomy. However, their clinical benefit has not been prospectively demonstrated. We …

Purpose: Prostatectomy is one of the main therapeutic options for prostate cancer (PCa).
Studies proved the benefit of adjuvant radiotherapy (aRT) on clinical outcomes, with more …

Aims Radiotherapy plays a fundamental role in the treatment of cancer. Currently, the
Brazilian public health system cannot match the national radiotherapy demand and many …

Abstract Background Positive surgical margins (PSMs) in radical prostatectomy (RP)
specimens are a frequent indication for adjuvant radiotherapy and are used as a measure of …

Highlights•This article provides ESMO expert recommendations adapted for the treatment of
prostate cancer in Asian patients.•The aim is to encourage evidence-based medicine and to …

Context The prognosis and optimal management of pN0/pN1 patients with persistently
elevated prostate-specific antigen (PSA) 6–8 wk after radical prostatectomy (RP) remain …

Purpose Our purpose was to compare toxicity and biochemical control in postprostatectomy
patients treated with conventional (66 Gy) or dose-intensified (72 Gy) radiation therapy …